Zhipeng Tao

3.3k total citations
33 papers, 518 citations indexed

About

Zhipeng Tao is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Zhipeng Tao has authored 33 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Physiology and 8 papers in Epidemiology. Recurrent topics in Zhipeng Tao's work include Adipose Tissue and Metabolism (8 papers), Autophagy in Disease and Therapy (6 papers) and Hippo pathway signaling and YAP/TAZ (6 papers). Zhipeng Tao is often cited by papers focused on Adipose Tissue and Metabolism (8 papers), Autophagy in Disease and Therapy (6 papers) and Hippo pathway signaling and YAP/TAZ (6 papers). Zhipeng Tao collaborates with scholars based in United States, China and South Korea. Zhipeng Tao's co-authors include Zhiyong Cheng, Xu Wu, Louise Zheng, Lin Liu, Zheng‐Bo Han, Yao Wang, Shiming Wang, Dongmin Liu, Longhua Liu and Aria F. Olumi and has published in prestigious journals such as Nature Communications, Oncogene and Chemical Engineering Journal.

In The Last Decade

Zhipeng Tao

31 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhipeng Tao United States 13 209 108 98 85 71 33 518
Hua‐Qin Wang China 17 371 1.8× 79 0.7× 76 0.8× 14 0.2× 77 1.1× 34 651
Shuhong Yang China 14 272 1.3× 28 0.3× 70 0.7× 29 0.3× 28 0.4× 54 891
Tingting Xiong China 15 363 1.7× 48 0.4× 104 1.1× 21 0.2× 133 1.9× 43 740
Wenxiang Zhang China 13 212 1.0× 20 0.2× 22 0.2× 33 0.4× 121 1.7× 47 558
Sayuri Nakamura Japan 11 79 0.4× 103 1.0× 15 0.2× 41 0.5× 33 0.5× 39 408
Junying Zheng United States 17 262 1.3× 37 0.3× 34 0.3× 34 0.4× 22 0.3× 28 625
Naoya Itsumura Japan 7 216 1.0× 37 0.3× 52 0.5× 13 0.2× 14 0.2× 10 1.0k
Changming Wang China 14 335 1.6× 75 0.7× 24 0.2× 80 0.9× 17 0.2× 57 979
Andreia F. Mósca Portugal 12 323 1.5× 21 0.2× 44 0.4× 26 0.3× 31 0.4× 14 495
Weidong Li China 15 405 1.9× 83 0.8× 147 1.5× 21 0.2× 30 0.4× 38 731

Countries citing papers authored by Zhipeng Tao

Since Specialization
Citations

This map shows the geographic impact of Zhipeng Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhipeng Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhipeng Tao more than expected).

Fields of papers citing papers by Zhipeng Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhipeng Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhipeng Tao. The network helps show where Zhipeng Tao may publish in the future.

Co-authorship network of co-authors of Zhipeng Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhipeng Tao. A scholar is included among the top collaborators of Zhipeng Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhipeng Tao. Zhipeng Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Zhipeng, et al.. (2025). The Functions of Major Gut Microbiota in Obesity and Type 2 Diabetes. Metabolites. 15(3). 167–167. 1 indexed citations
2.
Guo, Susu, Xiaodi Hu, Jennifer L. Cotton, et al.. (2025). VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300. eLife. 13. 1 indexed citations
3.
Tao, Zhipeng, et al.. (2025). Ni-Based Anionic Metal–Organic Framework for Efficient Separation of C2H2 from C2H4 and CO2 Mixtures. ACS Materials Letters. 7(2). 517–523. 9 indexed citations
5.
Guo, Susu, Xiaodi Hu, Jennifer L. Cotton, et al.. (2024). VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300. eLife. 13. 3 indexed citations
6.
Tao, Zhipeng, et al.. (2024). Cation exchange strategy of ellagic acid-based microporous metal-organic framework for efficient CO2/N2 and CO2/CH4 separation. Chemical Engineering Journal. 502. 157956–157956. 7 indexed citations
7.
Tao, Zhipeng, et al.. (2024). Facet-dependent reactive oxygen species generation regulates photocatalytic oxidation of benzylamines. Journal of Catalysis. 442. 115931–115931.
8.
Lin, Zhuoyuan, Shivani Agarwal, Song Tan, et al.. (2023). Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer. Oncogene. 42(26). 2126–2138. 15 indexed citations
9.
Azzi, Abdelhalim, et al.. (2023). The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway. iScience. 26(8). 107449–107449. 3 indexed citations
10.
Tao, Zhipeng, et al.. (2022). Molecular insights into the multifaceted functions and therapeutic targeting of high mobility group box 1 in metabolic diseases. Journal of Cellular and Molecular Medicine. 26(14). 3809–3815. 12 indexed citations
11.
Tao, Zhipeng & Xu Wu. (2022). Targeting Transcription Factors in Cancer: From “Undruggable” to “Druggable”. Methods in molecular biology. 2594. 107–131. 21 indexed citations
12.
Sun, Yang, Lu Hu, Zhipeng Tao, et al.. (2022). Pharmacological blockade of TEAD–YAP reveals its therapeutic limitation in cancer cells. Nature Communications. 13(1). 6744–6744. 70 indexed citations
13.
Hu, Lu, Zhipeng Tao, & Xu Wu. (2021). Insights into auto- S -fatty acylation: targets, druggability, and inhibitors. RSC Chemical Biology. 2(6). 1567–1579. 8 indexed citations
14.
Tao, Zhipeng, Limin Shi, Louise Zheng, et al.. (2021). Sirt1 coordinates with ERα to regulate autophagy and adiposity. Cell Death Discovery. 7(1). 53–53. 19 indexed citations
15.
Wu, Shulin, Christina Sharkey, Shahin Tabatabaei, et al.. (2020). Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland. Prostate Cancer and Prostatic Diseases. 23(3). 465–474. 22 indexed citations
16.
Liu, Lin, et al.. (2020). The applications and prospects of hydrophobic metal–organic frameworks in catalysis. Dalton Transactions. 50(1). 39–58. 47 indexed citations
17.
Tao, Zhipeng, Louise Zheng, Jing Luo, et al.. (2018). Estradiol signaling mediates gender difference in visceral adiposity via autophagy. Cell Death and Disease. 9(3). 309–309. 45 indexed citations
18.
Tao, Zhipeng, Longhua Liu, Louise Zheng, & Zhiyong Cheng. (2017). Autophagy in Adipocyte Differentiation. Methods in molecular biology. 1854. 45–53. 18 indexed citations
19.
Liu, Longhua, Zhipeng Tao, Louise Zheng, et al.. (2016). FoxO1 interacts with transcription factor EB and differentially regulates mitochondrial uncoupling proteins via autophagy in adipocytes. Cell Death Discovery. 2(1). 16066–16066. 46 indexed citations
20.
Wu, Qiang, Qiu‐Feng Cai, Zhipeng Tao, et al.. (2014). Purification and characterization of a novel angiotensin I-converting enzyme inhibitory peptide derived from abalone (Haliotis discus hannai Ino) gonads. European Food Research and Technology. 240(1). 137–145. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026